61 related articles for article (PubMed ID: 38439970)
1. Evaluating performance and applications of sample-wise cell deconvolution methods on human brain transcriptomic data.
Dai R; Chu T; Zhang M; Wang X; Jourdon A; Wu F; Mariani J; Vaccarino FM; Lee D; Fullard JF; Hoffman GE; Roussos P; Wang Y; Wang X; Pinto D; Wang SH; Zhang C; ; Chen C; Liu C
bioRxiv; 2023 Mar; ():. PubMed ID: 36993743
[TBL] [Abstract][Full Text] [Related]
2. Next-generation deconvolution of transcriptomic data to investigate the tumor microenvironment.
Merotto L; Zopoglou M; Zackl C; Finotello F
Int Rev Cell Mol Biol; 2024; 382():103-143. PubMed ID: 38225101
[TBL] [Abstract][Full Text] [Related]
3. Computational solutions for spatial transcriptomics.
Kleino I; Frolovaitė P; Suomi T; Elo LL
Comput Struct Biotechnol J; 2022; 20():4870-4884. PubMed ID: 36147664
[TBL] [Abstract][Full Text] [Related]
4. ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic data.
Teng PN; Schaaf JP; Abulez T; Hood BL; Wilson KN; Litzi TJ; Mitchell D; Conrads KA; Hunt AL; Olowu V; Oliver J; Park FS; Edwards M; Chiang A; Wilkerson MD; Raj-Kumar PK; Tarney CM; Darcy KM; Phippen NT; Maxwell GL; Conrads TP; Bateman NW
iScience; 2024 Mar; 27(3):109198. PubMed ID: 38439970
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer.
Schwede M; Waldron L; Mok SC; Wei W; Basunia A; Merritt MA; Mitsiades CS; Parmigiani G; Harrington DP; Quackenbush J; Birrer MJ; Culhane AC
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):509-519. PubMed ID: 31871106
[TBL] [Abstract][Full Text] [Related]
6. Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling.
Hunt AL; Bateman NW; Barakat W; Makohon-Moore SC; Abulez T; Driscoll JA; Schaaf JP; Hood BL; Conrads KA; Zhou M; Calvert V; Pierobon M; Loffredo J; Wilson KN; Litzi TJ; Teng PN; Oliver J; Mitchell D; Gist G; Rojas C; Blanton B; Darcy KM; Rao UNM; Petricoin EF; Phippen NT; Maxwell GL; Conrads TP
Clin Proteomics; 2024 Jan; 21(1):4. PubMed ID: 38254014
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology.
Sturm G; Finotello F; Petitprez F; Zhang JD; Baumbach J; Fridman WH; List M; Aneichyk T
Bioinformatics; 2019 Jul; 35(14):i436-i445. PubMed ID: 31510660
[TBL] [Abstract][Full Text] [Related]
8. Multimodal joint deconvolution and integrative signature selection in proteomics.
Pan Y; Wang X; Sun J; Liu C; Peng J; Li Q
Commun Biol; 2024 Apr; 7(1):493. PubMed ID: 38658803
[TBL] [Abstract][Full Text] [Related]
9. Decomprolute is a benchmarking platform designed for multiomics-based tumor deconvolution.
Feng S; Calinawan A; Pugliese P; Wang P; Ceccarelli M; Petralia F; Gosline SJC
Cell Rep Methods; 2024 Feb; 4(2):100708. PubMed ID: 38412834
[TBL] [Abstract][Full Text] [Related]
10. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways.
Soltis AR; Bateman NW; Liu J; Nguyen T; Franks TJ; Zhang X; Dalgard CL; Viollet C; Somiari S; Yan C; Zeman K; Skinner WJ; Lee JSH; Pollard HB; Turner C; Petricoin EF; Meerzaman D; Conrads TP; Hu H; ; Shriver CD; Moskaluk CA; Browning RF; Wilkerson MD
Cell Rep Med; 2022 Nov; 3(11):100819. PubMed ID: 36384096
[TBL] [Abstract][Full Text] [Related]
11. Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data.
Fisher NC; Byrne RM; Leslie H; Wood C; Legrini A; Cameron AJ; Ahmaderaghi B; Corry SM; Malla SB; Amirkhah R; McCooey AJ; Rogan E; Redmond KL; Sakhnevych S; Domingo E; Jackson J; Loughrey MB; Leedham S; Maughan T; Lawler M; Sansom OJ; Lamrock F; Koelzer VH; Jamieson NB; Dunne PD
Clin Cancer Res; 2022 Sep; 28(18):4056-4069. PubMed ID: 35792866
[TBL] [Abstract][Full Text] [Related]
12. Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment.
Mitchell D; Hunt AL; Conrads KA; Hood BL; Makohon-Moore SC; Rojas C; Maxwell GL; Bateman NW; Conrads TP
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35723500
[TBL] [Abstract][Full Text] [Related]
13. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences.
Perez-Riverol Y; Bai J; Bandla C; García-Seisdedos D; Hewapathirana S; Kamatchinathan S; Kundu DJ; Prakash A; Frericks-Zipper A; Eisenacher M; Walzer M; Wang S; Brazma A; Vizcaíno JA
Nucleic Acids Res; 2022 Jan; 50(D1):D543-D552. PubMed ID: 34723319
[TBL] [Abstract][Full Text] [Related]
14. Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.
Hunt AL; Bateman NW; Barakat W; Makohon-Moore S; Hood BL; Conrads KA; Zhou M; Calvert V; Pierobon M; Loffredo J; Litzi TJ; Oliver J; Mitchell D; Gist G; Rojas C; Blanton B; Robinson EL; Odunsi K; Sood AK; Casablanca Y; Darcy KM; Shriver CD; Petricoin EF; Rao UNM; Maxwell GL; Conrads TP
iScience; 2021 Jul; 24(7):102757. PubMed ID: 34278265
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
